Channels - Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Review :: FRELIP Discovery

Similar Items: Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Review

Quick Look
Oncolytic virus and PD-1/PD-L1 blockade combination therapy
Quick Look
Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer
Quick Look
A Novel Prognostic Model Based on Prognostic Nutritional Index and Systemic Immune-Inflammation Index for Cancer Patients Treated with Immune Checkpoint Inhibitors
Quick Look
Real‐World Survival Over 25 Years in Extensive‐Stage Small‐Cell Lung Cancer: The Impact of Immune Checkpoint Inhibitors
Quick Look
Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence
Quick Look
Intelligent nano‐platforms in breast cancer therapy: Current advances and future perspectives
Quick Look
Impact of Targeted Immune Checkpoint Inhibitor Adjuvant Therapy on Recurrence-Free Survival and Functional Recovery in Stage III Tongue Cancer Patients: A Retrospective Cohort Study
Quick Look
The Prognostic Value of Serum Inflammatory Markers in Nasopharyngeal Carcinoma Patients Treated With Immune Checkpoint Inhibitors: A Multicenter Study
Quick Look
Immune‐Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex)
Quick Look
Lipid Metabolic Reprogramming in Breast Cancer: Mechanisms and Emerging Therapeutic Strategies
Quick Look
Induced Electric Fields Inhibit Breast Cancer Growth and Metastasis and Modulate the Immune Tumor Microenvironment
Quick Look
Efficacy and Safety of Regorafenib with or without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Systematic Review and Arm-Level Synthesis of Real-World Comparative Cohorts
Quick Look
Supporting Patients With Breast Cancer and Providers Through Treatment and Survivorship: Multimethod Implementation Study of the MyJourney Platform
Quick Look
Chemo‐Immunotherapy, a Combination Approach for the Treatment of HER2‐Positive Breast Cancer in a Mouse Model
Quick Look
Hematologic Glyco-Signatures: Emerging Blood-Based Sugar Codes Linked to Hyper-Aggressive Breast Cancer
Quick Look
Prognostic and Predict Value of Peripheral Blood Circulating Tumor Cells Programmed Death‐Ligand 1 Expression and F‐18‐Fluorodeoxyglucose Metabolic Parameters in Patients With Advanced Non‐Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Quick Look
RAP80 Expression in Breast Cancer and Its Relationship with Apoptosis in Breast Cancer Cells [Retraction]
Quick Look
Molecular and genomic advances in breast cancer: A comprehensive review of predictive and therapeutic innovations
Quick Look
Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
Quick Look
Revealing the Interactions of Regulatory Factors in the Immune Microenvironment of Breast Cancer Based on Two‐Way Orthogonal Partial Least Square Model and Cell Communication
Quick Look
CEACAM1 participation in breast cancer progression
Quick Look
A narrative review of the occurrence of posttraumatic stress responses in adolescent and young adult cancer survivors
Quick Look
Fear of Cancer Recurrence and Coping in Young Breast Cancer Survivors: A Secondary Analysis
Quick Look
When “CAM” is not CAM: Interpreting national cancer database analyses in breast cancer